Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05088798 · ClinicalTrials.gov registry record · Phase 2
Utility of 18FDOPA PET/MRI for Focal Hyperinsulinism
A Phase 2 study of Hyperinsulinism, sponsored by Washington University School of Medicine.
- Recruiting
- Registry status
- Phase 2
- Development phase
- 100
- Enrollment target
- 1
- Study location
NCT05088798: Recruiting Phase 2 study of Hyperinsulinism, sponsored by Washington University School of Medicine.
NCT05088798 is a Phase 2 study of Hyperinsulinism that is actively recruiting participants, run by Washington University School of Medicine. The registered enrollment target is 100 participants, below the 187-participant average among 5 other Hyperinsulinism trials with a reported enrollment target (47% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05088798, a Phase 2 study of Hyperinsulinism, is actively recruiting participants, sponsored by Washington University School of Medicine.
- RECRUITING
- Registry status
- Phase 2
- Development phase
- 100 participants
- Enrollment target
- 1
- Study location
Study Summary
The purpose of the study is to provide access to 18F-DOPA PET to patients at Washington University and assess the utility of 18F-DOPA PET/MRI as a preoperative tool to detect and localize focal lesions in the pancreas that are causing hyperinsulinism.
Primary Outcome
To provide access to 18F-DOPA PET/MRI (or PET/CT) for patients with HI who do not respond to pharmacological therapy and are being considered for pancreatic surgery. We will measure this by totaling the number of scans performed yearly.
Conditions Studied
Interventions
- DRUG 18F-Fluoro Dopa PET/MRI Imaging
Study Locations (1)
Missouri
- Washington University - St Louis
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 100 participants |
| Start Date | 2020-09-10 |
| Est. Completion | 2030-01-01 |
| Phase | Phase 2 |
What NCT05088798 shows while recruiting
NCT05088798 is an interventional study that assigns participants to a tested intervention. The registered 100 participants enrollment target is mid-sized for trials with a published cap, below the 187-participant average among 5 other Hyperinsulinism trials with a reported enrollment target (47% lower).
The record links to 1 condition, with Hyperinsulinism appearing as the primary indexed condition, and to 1 intervention - of which 18F-Fluoro Dopa PET/MRI Imaging is the first listed.
NCT05088798 reports a single indexed study location in Missouri.
Frequently Asked Questions
What is clinical trial NCT05088798 about?
NCT05088798 is a clinical study titled "Utility of 18FDOPA PET/MRI for Focal Hyperinsulinism". The purpose of the study is to provide access to 18F-DOPA PET to patients at Washington University and assess the utility of 18F-DOPA PET/MRI as a preoperative tool to detect and localize focal lesions in the pancreas that are causing hyperinsulinism.
What is the current status of trial NCT05088798?
This trial is currently recruiting. It is a Phase 2 study. The enrollment target is 100 participants. The study started on 2020-09-10. Estimated completion is 2030-01-01.
What conditions does trial NCT05088798 study?
This clinical trial studies the following conditions: Hyperinsulinism.
What interventions are being tested in trial NCT05088798?
The interventions under investigation include: 18F-Fluoro Dopa PET/MRI Imaging (DRUG).
Who is sponsoring clinical trial NCT05088798?
This trial is sponsored by Washington University School of Medicine, which has 1,502 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05088798 being conducted?
This trial has 1 study location across Missouri. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Hyperinsulinism
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Utility of [F-18] fluoroDOPA for Neonatal Hyperinsulinism
COMPLETED · Phase 2
-
Fasting Insulin and HOMA-IR by Age, Sex, Race/Ethnicity, BMI, and PCOS Diagnosis
RECRUITING
-
Cognitive-Behavioral Therapy and Exercise Training in Adolescents At-Risk for Type 2 Diabetes
RECRUITING · NA
-
Study to Evaluate Biomarkers and Safety of Dapagliflozin Concomitant with Neoadjuvant Therapy
RECRUITING · Phase 1
-
Bionic Pancreas in Children With Hyperinsulinism and Post-Pancreatectomy Diabetes
COMPLETED · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01048281 · 100 participants
Clinical & Pathological Studies of Upper Gastrointestinal Carcinoma
- NCT01161199 · 100 participants
The Use of Leukapheresis to Support HIV Pathogenesis Studies
- NCT01327690 · 100 participants · Early Phase 1
Mental Health in Veterans and Families After Group Therapies
- NCT01730781 · 100 participants
Imaging Cannabinoid Receptors Using Positron Emission Tomography (PET) Scanning
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI